RETINITIS PIGMENTOSA 11

Clinical trials for RETINITIS PIGMENTOSA 11 explained in plain language.

Never miss a new study

Get alerted when new RETINITIS PIGMENTOSA 11 trials appear

Sign up with your email to follow new studies for RETINITIS PIGMENTOSA 11, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Experimental eye injections aim to halt rare genetic blindness

Disease control Recruiting now

This study is testing the safety and effectiveness of repeat injections of an experimental drug, VP-001, into the eye. It is for adults with a rare, inherited form of vision loss called PRPF31 mutation-associated retinal dystrophy. The goal is to see if the injections can help co…

Matched conditions: RETINITIS PIGMENTOSA 11

Phase: PHASE1, PHASE2 • Sponsor: PYC Therapeutics • Aim: Disease control

Last updated Mar 19, 2026 14:55 UTC

RETINITIS PIGMENTOSA 11

Get alerted when new RETINITIS PIGMENTOSA 11 trials appear

Experimental eye injections aim to halt rare genetic blindness